Vietnam's Pharmaceutical Landscape
As a developing country, Vietnam has experienced robust economic growth in the past several years. With a population
of over 97 million people, the country has become an attractive market for various
industries, including medicine. With growing technological innovations, Vietnam is the ideal destination to develop the pharmaceutical industry.
Challenges in Vietnam
Currently, Vietnam’s technological advancement and innovation in pharmaceutical R&D
remain in the early stages of growth. Moreover, Vietnam’s population is relatively young, with a
median age lower than many developed nations, making it challenging to expand the
pharmaceutical industry with low prevalence of age-related and chronic diseases.
Read More
(Vietnam Briefing, 2022)
Opportunities in Vietnam
On the other hand, the Vietnamese pharmaceutical market has shown steady growth with a compound annual growth rate of approximately 10%. This is expected to continue as the population ages further in the future and the prevalence of chronic diseases increases. Additionally, In Vietnam, customers tend to prioritize affordable and accessible healthcare options. As a result, generic drugs have become increasingly popular, accounting for a significant portion of the pharmaceutical market.
Read More
(Vietnam Plus, 2025)
Read More About What's Happening in Vietnam's Pharmaceutical Market
Stay informed and up-to-date with the evolving policies of Vietnamese law.
"Pharmaceutical exports reach $312 million, Viet Nam ranks fourth in Southeast Asia"
January 02, 2026
Overview
This article gives insights into Vietnam's fast paced growth towards the Pharmaceutical industry, with total market value to grow from USD 2.7 Billion in 2015 to approximately USD 8 Billion in 2026. A large portion of pharmaceutical firms are foreign-invested enterprises, contributing almost $230 million to export value in Vietnam's market (Vietnam News, 2026).
"Vietnam Pharmaceutical industry offers growing opportunities for investors in 2026"
April 08, 2026
Overview
This article discusses Vietnam's expanding domestic production in Pharmaceuticals, as well as growing partner relationships with large Pharmaceutical markets around the world including 54.3% of imports from the EU, and the rest from USA, India, France, Italy, among others (B&Company, 2026).
"Future Value of Vietnam's Generics Market"
October 10, 2025
Overview
World leading firm, KPMG, wrote a report on Vietnam's Generics market and growth prospects to 2029. Key highlights from the report include: rising healthcare costs and economic strain towards healthcare spending, attractive generic markets opportunity which is currently underutilized in the Vietnamese market, and challenges faced by firms including regulatory and investment barriers for drug registration in Vietnam (KPMG, 2025).
Key-Metrics on Vietnam's Pharma Consumer Trends
Health Insurance Holders in 2024 Vietnam
94%
Pharma Import value 2024 (Billions USD)
$4.4+
Expected Urbanization Rate by 2025
45%
Annual Growth Rate For Pharmaceuticals
10%
Manufacturing Plants
250
Import-Export Facilities
200+
Total Wholesale Agents
4,300
Total Retail Agents
62,000+